Navigation Links
Telbivudine Given to Mothers With Hepatitis B Reduces Infection Rate in Infants
Date:11/1/2010

ted to 28 weeks after birth. Even though it is good enough to define the failure rate of transmission prevention, the long term safety data for the infant is missing. Hypothetically, antiviral therapy and immunoprophylaxis can be effective in blocking transmission that occurs during late pregnancy or delivery, but the mechanism of intrauterine transmission remains a puzzle. More studies are needed in the field to provide a comprehensive strategy to prevent HBV vertical transmission."  

The message he wants to convey is still a positive one and shows a different way of attacking the problem of HBV. "Because we are struggling in combating the pandemic of hepatitis B worldwide, and frustrated in the limited resources we can allocate for treating our patients," said Dr. Pan, "Maybe we should be putting more efforts and allocating more resources on preventing HBV vertical transmission."

Abstract title:

A Prospective and Open-Label Study for the Efficacy and Safety of Telbivudine(Ltd) in Pregnancy for the Prevention of Perinatal Transmission of Hepatitis B Virus (HBV) to the Infants

About the AASLD

AASLD is the leading medical organization for advancing the science and practice of hepatology. Founded by physicians in 1950, AASLD's vision is to prevent and cure liver diseases. This year's Liver Meeting®, held in Boston, Massachusetts, October 29-November 2, will bring together more than 7,500 researchers from 55 countries.

A pressroom will be available from October 30 at the annual meeting. For copies of abstracts and press releases, or to arrange for pre-conference research interviews contact Gregory Bologna at 703-299-9766. To pre-register, call Ann Haran at 703-299-9766.

Press releases and all abstracts are available online at www.aasld.org.

This release was issued through The Xpress Press News Service, merging e-mail and satellite distribution tech
'/>"/>

SOURCE American Association for the Study of Liver Diseases (AASLD)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
2. UPDATE: Infant Primates Given Vaccines on U.S. Childrens Immunization Schedule Develop Behavioral Symptoms of Autism
3. DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix(TM) or Aspirin
4. Capecitabine Added to Standard Treatment Given Before Surgery Helps to Eradicate Tumours in Patients With Early Breast Cancer
5. Water Street Healthcare Partners Signs Definitive Agreement to Sell Sierra Scientific Instruments to Given Imaging
6. Reprogrammed Herpes Virus Given Systemically Before Anti-vascular Drug Shrinks Distant Sarcomas
7. New UNAIDS Report Offers Encouraging News, But Most HIV-Positive Mothers Still Not Getting the Care & Treatment They Need
8. Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds & Flu
9. Omega-3 Fatty Acids Critical to Infants, Mothers and the Seriously Ill
10. Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Dont Get Their Families Vaccinated
11. Survey Finds Mothers Take Childrens Health Into Their Own Hands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... SAN DIEGO , Aug. 31, 2015 ... announced today development of a novel means of ... nucleic acid, RGBP-248, to liver tumors utilizing a ... in development overcomes previous hurdles with gene silencing ... to be delivered throughout the whole body.  By ...
(Date:8/31/2015)... 31, 2015 BioLight ... BLGTY) ("BioLight" or the "Company"), a firm that ... ophthalmology and cancer diagnostics, today announced that its ... identified several new genetic markers with high potential ... treated with bisphosphonate drugs and was able to ...
(Date:8/31/2015)... ALBANY, N.Y. , Aug. 31, 2015 /PRNewswire/ ... a.s. today announced a strategic collaboration focused on ... of opium-derived active pharmaceutical ingredients, ("APIs"). The collaboration ... biomass and their expertise in developing and manufacturing ... their ability to tech transfer processes into these ...
Breaking Medicine Technology:Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 2AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 3AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 4
... April 20, 2012 West Physics Consulting, the leading ... testing services, announced today that it has entered into ... Mirion Technologies to provide dosimetry services. The ... of services and products to medical and industrial users ...
... 20, 2012 Rapid Fire Marketing (Pink Sheets: ... deal with a California Manufacturer to begin the development of the ... begin early next. Once all specifications are met, the manufacturing facility ... will also file for a patent of the new device once ...
Cached Medicine Technology:West Physics Consulting Teams with Mirion Technologies Dosimetry Services Division to Deliver Radiation Detection Services 2Rapid Fire Marketing Funds Development of Second Generation Vapor Inhaler 2
(Date:8/31/2015)... ... August 31, 2015 , ... American Family ... is enhancing its existing presence in Tennessee with the opening of a new ... company’s second in Knoxville, sixteenth in Tennessee, and 148th in the U.S. overall. ...
(Date:8/31/2015)... ... August 31, 2015 , ... People with hostile personality ... risk for injury, potentially because they are more susceptible to the influence of ... Public Health analysis discovered. , The research, published online in the International ...
(Date:8/31/2015)... Valley, CA (PRWEB) , ... August 31, 2015 , ... ... Ghasri, to the practice. Dr. Pedram Ghasri is a graduate of the University of ... neuroscience and continued his studies at the University of California, Irvine Medical School. As ...
(Date:8/31/2015)... ... August 31, 2015 , ... The German soccer ... management system (CMS) and make website updates quicker and more flexible. The company's ... of the Bundesliga (the German equivalent of the U.S. Soccer Federation) more modern, ...
(Date:8/31/2015)... ... August 31, 2015 , ... "While ... device that could effectively deliver oxygen with a lower risk of failure," explained ... way, I invented the Adam Device." , The Adam Device offers a quick, ...
Breaking Medicine News(10 mins):Health News:State-of-the-Art Urgent Care Facility Opening in Knoxville 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 3Health News:Castle Dermatology Institute Now Welcomes Dr. Pedram Ghasri to the Practice 2Health News:On the Ball with FirstSpirit: German Soccer League (DFL Digital Sports) Opts for e-Spirit’s CMS 2Health News:InventHelp® Client's Invents Medical Device to Restore Respiratory Function (BGF-905) 2
... community cooperation, building on skills and strengths, and getting strangers ... Now, a pilot study of six families living ... infusions of cash could fuel such cooperation and produce overlapping ... migrant workers have assets as well as significant health-care needs, ...
... used multivitamins during and after being treated with post-surgical chemotherapy ... their dying from it, according to researchers at Dana-Farber Cancer ... colon cancer characterized as cancer in the large bowel ... nodes -- the researchers found that while multivitamin use had ...
... Sinai School of Medicine have discovered a major mechanism ... The discovery may help researchers find new therapies to ... associated with morphine use. The findings are published in ... Overcoming tolerance to morphine after chronic administration has ...
... YORK, NY September 7, 2010 Clinical trials ... that will be presented at TCT 2010 will directly ... treated. Breakthroughs in science and medical research, presented exclusively ... minimally invasive and involve shorter recovery times. Among the ...
... HealthDay Reporter , TUESDAY, Sept. 7 (HealthDay News) ... expose children to the controversial chemical bisphenol A (BPA), a ... remains unclear whether or not it poses a long-term health ... saliva can cause the fillings and sealants to leach. This ...
... in primary care cut heart disease deaths and hospital ... published online in the Journal of Epidemiology and ... financial incentives to quality improvement has improved the overall ... far there has been little evidence to suggest that ...
Cached Medicine News:Health News:For migrant workers, community cooperation builds on individual strengths 2Health News:For migrant workers, community cooperation builds on individual strengths 3Health News:Multivitamin use doesn't impact colon cancer outcomes 2Health News:Mount Sinai researchers find new target to improve pain management 2Health News:TCT 2010 late breaking trials to have impact on practice of interventional cardiology 2Health News:TCT 2010 late breaking trials to have impact on practice of interventional cardiology 3Health News:TCT 2010 late breaking trials to have impact on practice of interventional cardiology 4Health News:Fillings, Sealants May Leach BPA Into Kids' Mouths 2Health News:Fillings, Sealants May Leach BPA Into Kids' Mouths 3Health News:Primary care financial incentives cut heart disease deaths and admissions 2
... a two chain (alpha- and beta-subunits) glycoprotein ... the placenta and is normally found in ... the trophoblastic epithelium of the placenta, hCG ... the early stages of pregnancy. The primary ...
... for movement is critical ... wheelchairs. Thats why this ... technology to do just ... state-of-the-art technology, these wheelchair ...
When patients are less mobile our ProPlus™ Stand-On Scale with built-in wheels moves easily to them. Extremely durable and safe, the easy grip handrail and non-skid platform provide added suppo...
... 100 provides a new screening, diagnostic, treatment ... medical management of sleep-related breathing disorders. The ... unmet need for an ambulatory, reliable, patient ... to the great number of OSA sufferers, ...
Medicine Products: